Overview Financials News + Filings IR Vault Key Docs Charts Transactions Holdings Ownership Insiders
|
| In millions, except per share items | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 | Sep-30-20 |
| | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q |
| Revenues |
| Pharmaceutical | 43,337.0 | 40,957.0 | 41,375.0 | 39,822.0 | 38,344.0 | 35,104.0 | 37,236.0 | 35,112.0 |
| Medical | 3,769.0 | 3,884.0 | 4,085.0 | 4,149.0 | 4,246.0 | 4,174.0 | 4,310.0 | 3,957.0 |
| |
| EBITDA |
| Pharmaceutical | 451.0 | 487.0 | 426.0 | 406.0 | 358.0 | 511.0 | 413.0 | 402.0 |
| Medical | -16.0 | 59.0 | 50.0 | 123.0 | -63.0 | 174.0 | 236.0 | 230.0 |
| |
| EBIT |
| Pharmaceutical | 451.0 | 487.0 | 426.0 | 406.0 | 358.0 | 511.0 | 413.0 | 402.0 |
| Medical | -16.0 | 59.0 | 50.0 | 123.0 | -63.0 | 174.0 | 236.0 | 230.0 |
| |
| Mix |
| Pharmaceutical | 92.0% | 91.3% | 91.0% | 90.6% | 90.0% | 89.4% | 89.6% | 89.9% |
| Medical | 8.0% | 8.7% | 9.0% | 9.4% | 10.0% | 10.6% | 10.4% | 10.1% |
| |
| Growth |
| Pharmaceutical | 13.0% | 16.7% | 11.1% | 13.4% | 15.4% | 0.0% | 4.3% | 5.0% |
| Medical | -11.2% | -6.9% | -5.2% | 4.9% | 23.0% | 3.0% | 7.1% | 1.0% |
|